In India, the A2 milk controversy has its roots in the milk revolution in India Between 1960s -1980s, cattle breeds like Jersey, Holstein, and Ayrshire breeds were introduced to boost the milk yield.5 This was coupled with reduced demand for indigenous breeds like Gir and Sahiwal. 5 Many of these indigenous breeds produce A2 milk6. Note that if an animal has A2A2 genotype only then it can be claimed to be producing A2 milk, otherwise it is termed as A1 milk.6
As there is some evidence that A2 milk is better digested by some individuals and may have certain health benefits over A1 milk, there has been a rise in demand for A2 milk and other dairy products over the last decade. Many brands are selling A2 milk and other dairy products at a premium price. The A2 milk market is driven by marketing claims that influence consumer perceptions and choices.
What consumers should look out for?
Consumers are paying a premium price for some A2 dairy products despite the lack of clear evidence supporting their superiority. Take the example of A2 ghee. It is the protein present in regular milk that is under scrutiny for potentially having adverse health impacts. However, any type of ghee, whether made from A2 or A1 milk, is just fat and does not contain protein. The FSSAI advisory released on 21st August 2024 aimed to curtail misleading claims made by brands. The advisory mandated the removal of A1 and A2 milk claims from dairy product labels.
On 26th August 2024, the FSSAI advisory dated 21st August 2024 was retracted following a letter by Mr. Venugopal Bhadarvada addressed to Shri Narendra Modi, Prime Minister of India. Bhadarvada, a member of the Indian Council for Agricultural Research (ICAR), urged in his letter for a more thorough examination of the issue by experts before implementing such regulations. The FSSAI’s withdrawal allows time for further consultation with stakeholders, acknowledging the complexity of the debate surrounding A1 and A2 milk and dairy products and its potential impact on consumer choices and the dairy industry.
The A1 & A2 milk controversy is a complex issue that intertwines science, regulation, and consumer perception. While the debate over the health implications of A1 and A2 milk continues, the FSSAI’s role is to ensure that consumers are informed and that their choices are guided by evidence rather than marketing hype.
References
- Bolat E, Eker F, Yılmaz S, Karav S, Oz E, Brennan C, Proestos C, Zeng M, Oz F. BCM-7: Opioid-like Peptide with Potential Role in Disease Mechanisms. Molecules. 2024 May 6;29(9):2161.
- Giribaldi M, Lamberti C, Cirrincione S, Giuffrida MG, Cavallarin L. A2 milk and BCM-7 peptide as emerging parameters of milk quality. Frontiers in nutrition. 2022 Apr 27;9:842375.
- Kay SI, Delgado S, Mittal J, Eshraghi RS, Mittal R, Eshraghi AA. Beneficial effects of milk having A2 β-casein protein: Myth or reality?. The Journal of nutrition. 2021 May 1;151(5):1061-72.
- Küllenberg de Gaudry D, Lohner S, Schmucker C, Kapp P, Motschall E, Hörrlein S, Röger C, Meerpohl JJ. Milk A1 β-casein and health-related outcomes in humans: A systematic review. Nutrition reviews. 2019 May 1;77(5):278-306.
- Taneja VK. Cattle breeding programmes in India.
- PN RJ. Detection of A1 and A2 milk in Tiruchirappalli district using TANUVAS A1A2 detect kit. Indian Journal of Dairy Science. 2022;75(3).